Search research articles
Contact Us
Filters
Showing results (231-240 of 304) with videos related to
Page
of 31
Sort By:
Cancers
|
August 7, 2021
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma
Stefanie Meyer, Diana Handke, Anja Mueller, et al.
Urologic Oncology
|
September 2, 2018
Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma
André Steven, Sandra Leisz, Sebastian Fussek, et al.
Cell Death Discovery
|
September 26, 2021
Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition
David Junk, Sebastian Krämer, Johannes Broschewitz, et al.
International Journal of Cancer
|
July 8, 2010
Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor
Katrin Singer, Michael Kastenberger, Eva Gottfried, et al.
Oncoimmunology
|
March 24, 2025
Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patients
Le Tong, Veronika Kremer, Shi Yong Neo, et al.
International Journal of Cancer
|
August 18, 2010
T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2
Kousaku Mimura, Takashi Ando, Isabel Poschke, et al.
Plos One
|
October 7, 2015
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
Riki Okita, Diana Wolf, Koichiro Yasuda, et al.
Cancer Immunology, Immunotherapy : CII
|
August 4, 2019
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
Michael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, et al.
Journal of Translational Medicine
|
March 7, 2025
Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers
Karthikeyan Subbarayan, Helena Bieber, Chiara Massa, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2020
Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity
Adi Reches, Yael Ophir, Natan Stein, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 304) with videos related to
Sort By:
Page
of 31
Cancers
|
August 7, 2021
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma
Stefanie Meyer, Diana Handke, Anja Mueller, et al.
Urologic Oncology
|
September 2, 2018
Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma
André Steven, Sandra Leisz, Sebastian Fussek, et al.
Cell Death Discovery
|
September 26, 2021
Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition
David Junk, Sebastian Krämer, Johannes Broschewitz, et al.
International Journal of Cancer
|
July 8, 2010
Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor
Katrin Singer, Michael Kastenberger, Eva Gottfried, et al.
Oncoimmunology
|
March 24, 2025
Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patients
Le Tong, Veronika Kremer, Shi Yong Neo, et al.
International Journal of Cancer
|
August 18, 2010
T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2
Kousaku Mimura, Takashi Ando, Isabel Poschke, et al.
Plos One
|
October 7, 2015
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
Riki Okita, Diana Wolf, Koichiro Yasuda, et al.
Cancer Immunology, Immunotherapy : CII
|
August 4, 2019
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
Michael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, et al.
Journal of Translational Medicine
|
March 7, 2025
Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers
Karthikeyan Subbarayan, Helena Bieber, Chiara Massa, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2020
Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity
Adi Reches, Yael Ophir, Natan Stein, et al.
Page
of 31